Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioCorRx (BICX) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for BioCorRx (BICX) over the last 17 years, with Q3 2025 value amounting to -$808502.0.

  • BioCorRx's Consolidated Net Income rose 4656.33% to -$808502.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.3 million, marking a year-over-year increase of 1389.53%. This contributed to the annual value of -$5.2 million for FY2024, which is 3823.41% down from last year.
  • Latest data reveals that BioCorRx reported Consolidated Net Income of -$808502.0 as of Q3 2025, which was up 4656.33% from -$1.4 million recorded in Q2 2025.
  • Over the past 5 years, BioCorRx's Consolidated Net Income peaked at -$808502.0 during Q3 2025, and registered a low of -$1.6 million during Q1 2021.
  • Moreover, its 5-year median value for Consolidated Net Income was -$1.2 million (2022), whereas its average is -$1.1 million.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first crashed by 7444.09% in 2024, then surged by 4656.33% in 2025.
  • BioCorRx's Consolidated Net Income (Quarter) stood at -$1.3 million in 2021, then rose by 8.36% to -$1.2 million in 2022, then increased by 16.68% to -$969009.0 in 2023, then decreased by 26.69% to -$1.2 million in 2024, then skyrocketed by 34.14% to -$808502.0 in 2025.
  • Its Consolidated Net Income was -$808502.0 in Q3 2025, compared to -$1.4 million in Q2 2025 and -$851764.0 in Q1 2025.